Awm Investment Company, Inc. Clene Inc. Transaction History

Awm Investment Company, Inc.

  • $732 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.26 - $0.55 $600,284 - $1.27 Million
-2,308,787 Reduced 46.18%
2,691,213 $807,000
Q2 2023

Aug 11, 2023
BUY
$0.78 - $1.22 $3.9 Million - $6.1 Million
5,000,000 New
5,000,000 $4.4 Million

Others Institutions Holding CLNN

# of Institutions
6
Shares Held
230K
Call Options Held
0
Put Options Held
25K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $273M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Awm Investment Company, Inc. Portfolio

Follow Awm Investment Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Awm Investment Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email